"Good Science or Good Business?"《好科学还是好商业？》

Healy, D. “Good Science or Good Business.” Hastings Center Report, March-April 2000.
Healy, D. “良好的科学还是良好的商业。” 黑斯廷斯中心报告，2000 年 3-4 月

David Healy is a psychiatrist and research scientist who has investigated the efficacy of psychopharmacological drugs and the conflicts of interest of psychopharmacological industry and psychiatric medicine. He has written over 20 books including Mania: A Short History and The Antidepressant Era. The essay you are reading, “Good Science or Good Business” critically examines regulatory changes regarding what constitutes disease, and the function of pharmaceutical corporations and argues for the power of treatment decisions to be “returned to the consumer.”
David Healy 是一名精神病学家和科研科学家，他研究过精神药理学药物的有效性和精神药理学行业与精神病学医学的利益冲突。他撰写了超过 20 本书，包括《狂躁：简史》和《抗抑郁时代》。您正在阅读的论文“良好的科学还是良好的商业”，批判性地审视了关于构成疾病以及制药公司功能的监管变化，并主张将治疗决策的权力“归还给消费者”。

📄 Good Science or Good Business? - Healy, D.GoodScienceorGoodBusiness.pdf